Exome sequencing directly implicates 68 genes in inflammatory bowel disease.

Area of Science:

• Genetics
• Immunology
• Gastroenterology

Background:

• Inflammatory bowel disease (IBD) is a chronic immune disorder with a complex genetic basis.
• Genome-wide association studies (GWAS) have identified many IBD risk variants, but most are in non-coding regions, hindering gene identification and biological interpretation.

Purpose of the Study:

• To identify protein-coding risk genes for IBD using large-scale whole-exome and whole-genome sequencing data.
• To resolve genetic ambiguities and nominate therapeutic targets for IBD.

Main Methods:

• Analysis of whole-exome and whole-genome sequencing data from 86,213 IBD cases and 478,363 controls of European ancestry.
• Identification of conditionally independent protein-coding associations across the allele frequency spectrum.

Main Results:

• Identification of 68 IBD genes directly implicated by protein-coding associations.
• Confirmation of newly implicated IBD genes through orthogonal genomic or pleiotropic evidence.
• Discovery of allelic series and non-additive effects at key loci like NOD2 and TYK2.

Conclusions:

• Large-scale sequencing effectively resolves IBD-associated genes and pathways that are ambiguous from non-coding associations alone.
• The findings provide a more direct pathway from human genetics to biological insights and therapeutic hypotheses for IBD.
• This study enhances our understanding of the genetic architecture of IBD and identifies potential targets for novel therapies.